Sean Duffy Sells 12,944 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 12,944 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $20.40, for a total transaction of $264,057.60. Following the transaction, the chief executive officer owned 411,861 shares in the company, valued at $8,401,964.40. This represents a 3.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Omada Health Stock Down 5.3%

Shares of NASDAQ OMDA traded down $1.07 during trading on Wednesday, reaching $19.11. 2,078,593 shares of the company traded hands, compared to its average volume of 1,227,378. The firm has a 50 day simple moving average of $20.15 and a 200-day simple moving average of $16.10. The stock has a market capitalization of $1.14 billion, a PE ratio of -70.78 and a beta of 1.73. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million during the quarter. As a group, research analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in Omada Health during the second quarter valued at about $32,000. Bellevue Group AG grew its position in shares of Omada Health by 0.7% during the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after purchasing an additional 1,791 shares in the last quarter. Quarry LP purchased a new stake in shares of Omada Health during the fourth quarter worth about $29,000. Barclays PLC raised its stake in Omada Health by 14.6% during the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares during the period. Finally, TD Waterhouse Canada Inc. purchased a new position in Omada Health in the 4th quarter worth approximately $32,000.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Wall Street Zen lowered shares of Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. Barclays upped their price objective on Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research report on Monday. Weiss Ratings downgraded Omada Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, July 13th. Citizens Jmp raised their target price on Omada Health from $21.00 to $27.00 and gave the stock a “market outperform” rating in a research report on Monday, July 20th. Finally, Wells Fargo & Company boosted their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and an average target price of $24.75.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.